Participated · Seed · Mar 2026

Remi Health is building an alternative testing platform that supplies diagnostics infrastructure for healthcare providers, enabling the processing of large testing volumes quickly and reliably. Before seeking outside capital, the company had already processed more than 1 million tests, demonstrating meaningful product-market traction. Its solution addresses the growing workforce shortage in healthcare by automating and decentralizing parts of the diagnostics workflow. With fresh capital, management plans to scale operations across Europe’s fragmented healthcare systems, refine go-to-market execution, and improve unit economics. Founders Marvin Abert, Anthony Bielenstein, and André Lange emphasize operational reliability and resilience as key differentiators. The recent seed financing equips the team to move from proof-of-concept to large-scale deployment while continuing to educate generalist investors about the diagnostics space. The round’s completion allows leadership to pivot attention back from fundraising to product development and market expansion.